Hanane Ben-Taleb
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Hanane Ben-Taleb has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Amal Badre
Neonatal Reanimation Department (P4), Children's Hospital A. Harouchi, CHU Ibn Rochd, Faculty of Medicine and Pharmacy of Casablanca, Hassan II University of Casablanca , Casablanca
1 shared publication - Amine Lamrissi
Maternity Service, Mother and Child Hospital Abderrahim Harouchi, University Hospital IBN ROCHD of Casablanca, Morocco; Gynecology Obstetric Department, Faculty of Medicine and Pharmacy of Casablanca, Hassan 2 University of Casablanca, Morocco; Biology and Health Laboratory (LBS), Hassan 2 University of Casablanca, Morocco
1 shared publication - Azeddine Chakroun
Laboratory of Biology and Health, Research Center of Biotechnology and Health, Faculty of Sciences Ben M'Sik, Hassan II University of Casablanca , Casablanca
1 shared publication - Hanane Salih-Alj
Laboratory of Biology and Health, Research Center of Biotechnology and Health, Faculty of Sciences Ben M'Sik, Hassan II University of Casablanca , Casablanca
1 shared publication - Hind Sebbah
Laboratory of Pediatric Research, Inflammation Unit, Faculty of Medicine, and ULB Center for Immunology, Université Libre de Bruxelles (ULB) , Brussels
1 shared publication - Mustapha Chamekh
Inflammation Unit, Laboratory of Pediatric Research, Faculty of Medicine, Université Libre de Bruxelles, Brussels, Belgium
1 shared publication
Latest Publications
- 11 February 2026
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 233 (5) , 888-898
Inflammatory Cytokine Profile in Pregnant Women Colonized With Group B Streptococcus Reveals IL-17a as a Potential Biomarker to Identify at-risk Newborns
Background: Group B Streptococcus (GBS) is a commensal vaginal bacterium that can lead to adverse maternal and neonatal outcomes. In low or middle-income countries, few data are available regarding the immune-inflammatory response in GBS-colonized pregnant mothers and its association with the risk of neonatal invasive disease. In this investigation, we implement a prospective study on a cohort of mother–newborn dyads in Morocco to assess the cytokine profile in GBS-colonized-mothers whose newborns have invasive GBS disease. Methods: Pregnant women between 35 and 40 weeks of gestation were screened for vaginal colonization by GBS and followed up until delivery. A panel of inflammatory cytokines was quantified by Luminex multiplex assays and by ELISA in maternal and cord blood, as well as in supernatants after stimulation of pathogen recognition receptors. GBS-colonized-mothers were clustered according to clinical and inflammation markers and to their newborn's infection status. Results: GBS-colonized-mothers whose newborns developed invasive GBS disease exhibited significantly lower IL-1β, IL-4, and IL-17A production compared with GBS-colonized-mothers with healthy newborns. Similar results were obtained following ex vivo stimulation of peripheral blood cells by TLR4 and TLR1/2 ligands. The level of circulating maternal IL-17A had a higher significant predictive value for GBS transmission leading to invasive neonatal disease. Conclusions: This study shows that GBS-colonized-mothers may exhibit a greater cytokine inflammatory response compared with noncolonized-mothers. Regarding mother–newborn dyads, maternal IL-17A, a key mediator of antibacterial defense, emerges as a significant prognostic biomarker for assessing the risk of GBS transmission and the development of neonatal GBS invasive disease.
- 11 February 2026
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 233 (5) , 888-898
Inflammatory Cytokine Profile in Pregnant Women Colonized With Group B Streptococcus Reveals IL-17a as a Potential Biomarker to Identify at-risk Newborns
Background: Group B Streptococcus (GBS) is a commensal vaginal bacterium that can lead to adverse maternal and neonatal outcomes. In low or middle-income countries, few data are available regarding the immune-inflammatory response in GBS-colonized pregnant mothers and its association with the risk of neonatal invasive disease. In this investigation, we implement a prospective study on a cohort of mother–newborn dyads in Morocco to assess the cytokine profile in GBS-colonized-mothers whose newborns have invasive GBS disease. Methods: Pregnant women between 35 and 40 weeks of gestation were screened for vaginal colonization by GBS and followed up until delivery. A panel of inflammatory cytokines was quantified by Luminex multiplex assays and by ELISA in maternal and cord blood, as well as in supernatants after stimulation of pathogen recognition receptors. GBS-colonized-mothers were clustered according to clinical and inflammation markers and to their newborn's infection status. Results: GBS-colonized-mothers whose newborns developed invasive GBS disease exhibited significantly lower IL-1β, IL-4, and IL-17A production compared with GBS-colonized-mothers with healthy newborns. Similar results were obtained following ex vivo stimulation of peripheral blood cells by TLR4 and TLR1/2 ligands. The level of circulating maternal IL-17A had a higher significant predictive value for GBS transmission leading to invasive neonatal disease. Conclusions: This study shows that GBS-colonized-mothers may exhibit a greater cytokine inflammatory response compared with noncolonized-mothers. Regarding mother–newborn dyads, maternal IL-17A, a key mediator of antibacterial defense, emerges as a significant prognostic biomarker for assessing the risk of GBS transmission and the development of neonatal GBS invasive disease.